Ketesse (Dexketoprofen)

Dexketoprofen blocks both cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, it diminishes inflammation, peripheral sensitisation, and the transmission of pain signals, resulting in faster and effective analgesia.

The exact dose of Ketesse is determined by the prescribing healthcare professional based on the patient’s condition, severity of pain, and individual risk factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for dexketoprofen in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Ketesse, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketesse (dexketoprofen) is the S‑enantiomer of ketoprofen, offering a faster onset of analgesia and potentially lower gastrointestinal side‑effects compared with racemic mixtures. Compared with ibuprofen or naproxen, it may provide comparable pain control at lower doses, but individual response varies.

Ketesse should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and heat sources to maintain its stability and potency throughout its shelf life.

Ketesse is taken orally, usually with a glass of water. It can be taken with or without food, but patients with a sensitive stomach may benefit from taking it with meals to reduce gastrointestinal discomfort.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, renal impairment, and cardiovascular events like myocardial infarction or stroke. Patients should seek immediate medical attention if they experience symptoms such as severe abdominal pain, blood in stool, sudden swelling, or difficulty breathing.

Ketesse should be avoided in individuals with known hypersensitivity to dexketoprofen or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, uncontrolled hypertension, and in patients taking anticoagulants without close monitoring. A healthcare professional should evaluate suitability before prescribing.